About us
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
- Website
-
https://www.delee.co/
External link for Delee Corp
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- California
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
Locations
-
Primary
Get directions
California, US
Employees at Delee Corp
-
Joost Leeflang
broad experience in bringing people together and providing them and/or their organisations a new perspective
-
J. David Wong-Campos
Postdoctoral Researcher @ Harvard University | PhD in Physics
-
Ernesto Velarde Gonzalez
Advisory Committee en Delee Corp
-
Juan Felipe Yee
Co-Founder, CMO, and Director at Delee Corp.